Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

InaD-Like (INADL) Peptid

INADL Reaktivität: Human Wirt: Synthetic BP, BI
Produktnummer ABIN5686829
  • Target Alle PATJ (INADL) Produkte
    PATJ (INADL) (InaD-Like (INADL))
    Spezies
    Human
    Quelle
    • 2
    Synthetic
    Applikation
    Blocking Peptide (BP), BioImaging (BI)
    Produktmerkmale
    INADL peptide corresponds to 15 amino acids of INADL.
  • Applikationshinweise
    INADL Peptide is used for blocking the activity of INADL antibody . The INADL antibody ships at 0.5 mg/mL and the INADL Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μLwater, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Rekonstitution
    INADL peptide is supplied as 100 µg of dried peptide. When the peptide is reconstituted in 200 µL water, the concentration will be 0.5 mg/mL.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    Store at -20°C. When reconstituted minimize freezing and thawing.
  • Target
    PATJ (INADL) (InaD-Like (INADL))
    Synonyme
    wu:fc76h08 Peptide, si:dz129i22.4 Peptide, si:busm1-129i22.4 Peptide, Cipp Peptide, InaD-like Peptide, PATJ Peptide, hINADL Peptide, Patj Peptide, Inadl2 Peptide, RGD1565362 Peptide, PATJ, crumbs cell polarity complex component Peptide, patj Peptide, PATJ Peptide, Patj Peptide
    Gen-ID
    10207
    NCBI Accession
    NP_795352
    OMIM
    112382257
    UniProt
    Q8NI35
Sie sind hier:
Kundenservice